Gauri A Patwardhan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Gauri A Patwardhan

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Molecular Cancer|June 15, 2010

Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signalingYong-Yu Liu, Vineet Gupta, Gauri A Patwardhan, et al.

Cancer Research|November 23, 2016

Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast CancerVikram B Wali, Casey G Langdon, Matthew A Held, et al.

Cancers|September 11, 2020

Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer CellsMichal Marczyk, Gauri A Patwardhan, Jun Zhao, et al.

Oncotarget|April 21, 2017

Mitotic read-out genes confer poor outcome in luminal A breast cancer tumorsJavier Pérez-Peña, Ana Alcaraz-Sanabria, Cristina Nieto-Jiménez, et al.

Plos One|September 11, 2009

A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosisGauri A Patwardhan, Qian-Jin Zhang, Dongmei Yin, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Molecular Cancer|June 15, 2010

Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signalingYong-Yu Liu, Vineet Gupta, Gauri A Patwardhan, et al.

Cancer Research|November 23, 2016

Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast CancerVikram B Wali, Casey G Langdon, Matthew A Held, et al.

Cancers|September 11, 2020

Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer CellsMichal Marczyk, Gauri A Patwardhan, Jun Zhao, et al.

Oncotarget|April 21, 2017

Mitotic read-out genes confer poor outcome in luminal A breast cancer tumorsJavier Pérez-Peña, Ana Alcaraz-Sanabria, Cristina Nieto-Jiménez, et al.

Plos One|September 11, 2009

A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosisGauri A Patwardhan, Qian-Jin Zhang, Dongmei Yin, et al.

Pageof 2